Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian Cohort
Fabry disease (FD) is a multisystem lysosomal storage disorder induced by genetic variants in the alpha-galactosidase A (αGalA) gene. Some FD patients have GLA variants with a reduction in overall αGalA enzymatic activity due to mutated proteins with reduced stability, caused by protein misfolding a...
Saved in:
Main Authors: | Sebastián Jaurretche (Author), Santiago Alonso (Author), Mónica Calvo (Author), Sebastián Fernandez (Author), Heber Figueredo (Author), Beatriz Galli (Author), Ivanna Marin (Author), Andrés Martinez (Author), Silvia Mattausch (Author), Fernando Perretta (Author), Juan Politei (Author), Juan Ignacio Rolon (Author), Esteban Calabrese (Author) |
---|---|
Format: | Book |
Published: |
Hindawi - Cambridge University Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Migalastat como monoterapia oral para la enfermedad de Fabry
by: Fernando Javier Perretta, et al.
Published: (2023) -
Enfermedad de Fabry: un año en tratamiento con migalastat
by: Juan Camilo Vasquez Gomez, et al.
Published: (2022) -
Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report
by: Natalja Haninger-Vacariu, et al.
Published: (2019) -
Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report
by: Valeria Di Stefano, et al.
Published: (2021) -
Consideraciones adicionales al consenso colombiano de expertos sobre recomendaciones basadas en evidencias para el diagnóstico, el tratamiento y el seguimiento de la enfermedad de Fabry con compromiso renal
by: Sebastian Jaurretche
Published: (2023)